NDAINTRAVENOUSSOLUTION
Approved
Oct 2016
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Data completeness
5/8 — Partial
CARNEXIV (carbamazepine) by Lundbeck is mechanism of action carbamazepine has demonstrated anticonvulsant properties in rats and mice with electrically and chemically induced seizures. Approved for epilepsy. First approved in 2016.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CARNEXIV is an intravenous formulation of carbamazepine, a small-molecule anticonvulsant approved in 2016 for epilepsy treatment. It reduces polysynaptic responses and blocks post-tetanic potentiation, with an active metabolite (carbamazepine-10,11-epoxide) contributing to anticonvulsant effects. The drug is chemically unrelated to other anticonvulsants and was historically used for trigeminal neuralgia, though its exact mechanism of action remains incompletely understood.
Peak13.7 years to LOE
CARNEXIV is in peak lifecycle phase with a 13.8-year patent runway, suggesting stable commercial operations and sustained team investment through 2040.
Mechanism of Action
Mechanism of Action Carbamazepine has demonstrated anticonvulsant properties in rats and mice with electrically and chemically induced seizures. It appears to act by reducing polysynaptic responses and blocking the post-tetanic potentiation. Carbamazepine greatly reduces or abolishes pain induced…
Indications (1)
Clinical Trials (20)
Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole
Started Apr 2026
28 enrolled
Healthy Participants
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
Started Mar 2026
48 enrolled
Healthy Volunteers
A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults
Started Feb 2026
54 enrolled
Healthy Volunteer
To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants
Started Dec 2025
36 enrolled
HealthyVolunteer
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
Started Sep 2025
12 enrolled
Healthy Adults
Worked on CARNEXIV at Lundbeck? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.